Key result
Stammering is associated with chronic and social anxiety, highlighting the need for treatment protocols that directly target the social fears associated with the condition.
Highlights the need to understand the social fears associated with stammering and develop targeted treatment protocols.
May support anxiety screening in stammering; leaves open efficacy of targeted protocols pending trials.
Stammering results in involuntary disruption of a person's capacity to speak. It begins at an early age and can persist for life for at least 20% of those stammering at 2 years old. Although the aetiological role of anxiety in stammering has not been determined, evidence is emerging that suggests people who stammer are more chronically and socially anxious than those who do not. This is not surprising, given that the symptoms of stammering can be socially embarrassing and personally frustrating, and have the potential to impede vocational and social growth. Implications for DSM–IV diagnostic criteria for stammering and current treatments of stammering are discussed. We hope that this article will encourage a better understanding of the consequences of living with a speech or fluency disorder as well as motivate the development of treatment protocols that directly target the social fears associated with stammering.
No takes yet. Share an insight, caveat, or question.
Craig et al. (2006) conducted a review in Stammering. Stammering vs. People who do not stammer was evaluated. Stammering is associated with chronic and social anxiety, highlighting the need for treatment protocols that directly target the social fears associated with the condition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: